Residues in the Ligand Binding Domain That Confer Progestin or Glucocorticoid Specificity and Modulate the Receptor Transactivation Capacity von Robin-Jagerschmidt, Catherine, Wurtz, Jean-Marie, Guillot, Benoı̂t, Gofflo, Dominique, Benhamou, Brigitte, Vergezac, Agnès, Ossart, Christèle, Moras, Dino, Philibert, Daniel

Volltext

Abstract 1785: Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using Cross-Over-Dual-Variable-Domain (CODV) format for the treatment of acute myeloid leukem... von Bonnevaux, Helene, Guerif, Stephane, Albrecht, Jana, Jouannot, Erwan, Bassinet, Laurent, Vergezac, Agnès, Beil, Christian, Lange, Christian, Leuschner, Wulf Dirk, Caron, Anne, Amara, Celine, Barriere, Cedric, Siavellis, Justine, Bardet, Valerie, Luna, Ernesto, Drake, Donald, Rao, Ercole, Oprea, Corina, Wonerow, Peter, Carrez, Chantal, Blanc, Veronique, Hsu, Karl, Wiederschain, Dmitri, Fraenkel, Paula G.

Volltext

Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization von Bocquel, Marie-Thérèse, Ji, Jingwei, Ylikomi, Timo, Benhamou, Brigitte, Vergezac, Agnès, Chambon, Pierre, Gronemeyer, Hinrich

Volltext

A Single Amino Acid That Determines the Sensitivity of Progesterone Receptors to RU486 von Benhamou, Brigitte, Garcia, Teresa, Lerouge, Thierry, Vergezac, Agnes, Gofflo, Dominique, Bigogne, Claire, Chambon, Pierre, Gronemeyer, Hinrich

Volltext